Table 1. Number (%) of people with MS currently taking each medication, duration and number (%) previously taking each medication.
| Class of medication | Medication name | Number currently taking | Time taken (years)** | Number previously taking | |||
| n = 2276 | < 1 year | 1–10 years | 10+ years | Missing* | n = 2276 | ||
| First generation DMDs | Glatiramer acetate | 488 (21.4) | 125 (25.6) | 321 (65.8) | 25 (5.1) | 17 (3.5) | 345 (15.2) |
| Interferons | 433 (19.0) | 100 (23.1) | 266 (61.4) | 51 (11.8) | 16 (3.7) | 570 (25.0) | |
| Second generation DMDs | Natalizumab | 132 (5.8) | 56 (42.4) | 70 (53.0) | 1 (0.8) | 5 (3.8) | 77 (3.4) |
| Alemtuzumab | 2 (0.1) | 2 (100) | 0 (0) | 0 (0) | 0 (0) | 3 (0.1) | |
| Daclizumab | 1 (0.1) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 2 (0.1) | |
| Rituximab | 2 (0.1) | 1 (50.0) | 1 (50.0) | 0 (0) | 0 (0) | 5 (0.2) | |
| Fingolimod | 94 (4.1) | 71 (75.5) | 22 (23.4) | 0 (0) | 1 (1.1) | 25 (1.1) | |
| Dimethyl fumarate | 22 (1.0) | 9 (40.9) | 11 (50.0) | 0 (0) | 2 (9.1) | 7 (0.3) | |
| Teriflunomide | 4 (0.2) | 0 (0) | 3 (75.0) | 0 (0) | 1 (25.0) | 0 (0) | |
| Cladribine | 2 (0.1) | 2 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Laquinimod | 3 (0.1) | 0 (0) | 3 (0.1) | 0 (0) | 0 (0) | 2 (0.1) | |
| General immunosuppressants | Azathioprine | 7 (0.3) | 6 (85.7) | 1 (14.3) | 0 (0) | 0 (0) | 22 (1.0) |
| Cyclophosphamide | 1 (0.1) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 14 (0.6) | |
| Methotrexate | 5 (0.2) | 2 (40.0) | 3 (60.0) | 0 (0) | 0 (0) | 26 (1.1) | |
| Mitoxantrone | 4 (0.2) | 3 (75.0) | 0 (0) | 0 (0) | 1 (25.0) | 45 (2.0) | |
| Mycophenolate | 5 (0.2) | 2 (40.0) | 3 (60.0) | 0 (0) | 0 (0) | 3 (0.1) | |
| Steroids | Adrenocorticotropic hormone (ACTH) | 9 (0.4) | 2 (22.2) | 0 (0) | 0 (0) | 7 (77.8) | 28 (1.2) |
| Prednisolone | 144 (6.3) | 99 (68.7) | 15 (10.4) | 7 (4.9) | 23 (16.0) | 756 (33.2) | |
| Others | Immunoglobulins | 5 (0.2) | 1 (20.0) | 4 (80.0) | 0 (0) | 0 (0) | 23 (1.0) |
| Plasmapheresis | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 11 (0.5) | |
| LDN | 163 (7.2) | 44 (27.0) | 111 (68.1) | 3 (1.8) | 5 (3.1) | 67 (2.9) | |
| Minocycline | 16 (0.7) | 9 (56.2) | 7 (43.8) | 0 (0) | 0 (0) | 13 (0.6) | |
| Baclofen | 242 (10.6) | 57 (23.6) | 147 (60.7) | 29 (12.0) | 9 (3.7) | 127 (5.6) | |
| Fampridine | 80 (3.5) | 40 (50.0) | 36 (45.0) | 1 (1.2) | 3 (3.8) | 36 (1.6) |
DMD: disease-modifying drug; Low-dose naltrexone; MS: multiple sclerosis.
*
Data for time taking medication not provided by respondent
**
Denominator is variable based on number currently taking specific medication.